MedTrace Logo

Using Ambu Aura-i Laryngeal Mask Airway in Cranial Surgery

NCT04582227 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2024-01-17

No results posted yet for this study

Summary

the investigators hypothesize that Ambu aura-i LMA can be used safely in patients undergoing craniotomies and are effective in reducing the incidence of emergence hypertension.

Conditions

  • Hypertension, Malignant
  • Airway Management

Interventions

DEVICE

Ambu aura-i LMA

The ETT or the LMA will be inserted with the patient's head position is aided either by pins or head rest, and either the head will be in neutral position or tilted as long as the airway device is successfully placed.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Amr s wahdan, MD · Cairo University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2023-05-10
Completion
2023-06-22

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04582227 on ClinicalTrials.gov